“Lilly decided to terminate its phase 2b study (KDAF) of peresolimab in rheumatoid arthritis following Lilly’s analysis of the overall benefit/risk profile of peresolimab. This decision by ...
DALLAS (KDAF) — Espresso martinis are taking a seat at the table this Thanksgiving, with a new recipe from Reynolds Wrap.